I have been following there recommendations on DIA, SPY and QQQQ and find them accurate and timely. Well done for a solid service. I want to tell you that I can't compare anyone to them in terms of the daily analysis. For someone like me, who is familiar with technical analysis and has used it for two decades, it is very rare to hear from anyone who will share their analysis like they do. Watch the daily video its free, and maybe it can help you like it has helped me.
Visit StockMarketVideot (Google them)
Whatever happened to the MAKO stock anyway? The stock went from 20 to 48 then down to 14...then it went to 29.99 where it stayed for the longest time. Now as of this week, it's completely gone...??
A ten-bagger dead money? Neither of these companies needs the other at all. SYK bought a robotic company a couple of year ago that does knees and hip replacements. A company called MAKO. So SYK had a robotic arm .....so to say. ISRG has so much more room to grow globally.
SYK CEO mentioned robotics on CNBC this morning. ISRG has been pretty much dead money for some time. Any thoughts why the two companies shouldn't become one? Over the years there has been some talk of GE doing this with their medical business but frankly GE is still a mismanaged company even with the plan to divest much of their financial business. Any thoughts? Note I am new to this board but have owned ISRG for more than a decade and it is one of my very few ten-baggers.
I like Waters (WAT) which is sitting on about $18/share cash.
( but I'm not gem).
Also, when it backs off a bit I like Irish company ICLR for its clinical trials provider business, competitiveness and financials.
A "oddball" I have and love is CALM which is a $billion egg company with great financials and excellent dividend. Compare its long term chart with any other stock.
For India (where I worked for several years), I like IBN, one of the best managed banks in the world.
I was thinking about selling but the new CEO is doing a pretty good job of making over SYK into a leading medical device company again. Good for all involved.
Stryker—The maker of medical devices fell a penny short of estimates with adjusted quarterly profit of $1.44 per share, while revenue was in line. Stryker saw its profit hurt by higher recall costs and the impact of foreign exchange rates. Find out here: PennystockwinnnersDOTcom
[remove DOT and use . for link] or Google them.